Selank Peptide Dosing: What Research Shows and What Patients Should Know

There is no FDA-approved Selank dose in the United States, and Chia does not offer Selank. Published and online protocols vary widely, often discussing intranasal use and short courses, but the human evidence is limited and largely from Russian clinical research. Anyone considering Selank should review risks, legality, quality, and alternatives with a licensed clinician.

What is Selank, and why are people searching for dosing guidance?

Selank is a synthetic heptapeptide, meaning it is made of 7 amino acids. It is based on tuftsin, a small immune-related peptide, and its full sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro 2.

Selank as a synthetic tuftsin-derived heptapeptide

Selank is also called TP-7. Secondary research summaries describe it as a tuftsin analog developed in Russia, with added proline-containing amino acids that may change stability and activity compared with tuftsin itself 2.

Common claimed uses: anxiety, stress resilience, focus, and immune signaling

People usually search Selank because it is discussed as an anxiolytic nootropic peptide, meaning a compound studied for anxiety-like symptoms and cognition. Mechanistic summaries describe possible links to GABA-A receptor modulation, enkephalins, serotonin, dopamine, noradrenaline, BDNF, NGF, and immune signaling, but these mechanisms do not prove clinical benefit or define a safe human dose 2.

Why dosing information is hard to verify

Dosing is hard to verify because Selank does not have U.S. prescribing information, an FDA-approved label, or a standardized U.S. product. FDA-approved dosing is tied to a specific reviewed drug product, route, strength, indication, and safety data package 6.

Is there an official Selank dosage?

No official U.S. Selank dosage exists because Selank is not FDA-approved in the United States. Online dosing charts may describe what other people or research communities discuss, but they are not the same as prescribing information reviewed by the FDA 6.

What it means for a drug to have an approved dose

For an approved drug, the label lists the studied indication, route, strength, dose range, contraindications, warnings, and adverse reactions. FDA explains that approval is based on evidence that the drug’s benefits outweigh its known risks for the intended use 6.

Why U.S. patients should not treat online dosing charts as medical guidance

A Selank spray, vial, or bottle sold online may differ in concentration, purity, sterility, and delivered amount per spray. FDA warns that compounded and non-approved products can carry quality and safety risks, especially when used without medical oversight 7.

How Russian clinical use differs from U.S. regulatory status

Several secondary summaries describe Russian clinical use of Selank for generalized anxiety disorder and neurasthenia, including comparisons with benzodiazepine-class medications such as medazepam 2. That does not create an FDA-approved dose in the United States, and the available English-language evidence is not the same as a modern U.S. approval package 6.

What dosing ranges are discussed in published and online Selank protocols?

Reported Selank ranges vary widely, especially between intranasal administration and subcutaneous administration. The numbers below are educational summaries of ranges discussed in secondary sources; they are not instructions, recommendations, or Chia protocols 3.

Educational dosing chart: reported ranges only, not recommendations

Some online guides list Selank in micrograms per day, while others describe sprays, drops, or cycles. This can be misleading because “one spray” is not a dose unless the concentration and delivered volume are verified 3.

Intranasal Selank protocols discussed in secondary sources

Most patient-facing Selank discussions involve intranasal administration. The reason is practical: Selank has been described in Russian use as a nasal peptide, and nasal delivery is often discussed for peptides intended to act in the central nervous system 2.

Subcutaneous Selank protocols discussed in research-use communities

Subcutaneous Selank appears more often in research-use communities than in formal medical guidance. That route adds risks tied to sterile technique, injection-site reactions, contamination, and dose-calculation errors 7.

Why dose per spray, product concentration, and purity can change the actual amount delivered

Two bottles labeled “Selank nasal spray” can deliver different amounts if the concentration, pump volume, or peptide purity differs. This is one reason no-prescription peptide sourcing is not the same as a licensed-provider evaluation with pharmacy controls 7.

Can Selank be taken twice a day?

Some online Selank protocols split doses, but split dosing is not proof of safety or benefit. Without FDA labeling or strong dose-response trials, timing questions should be handled by a clinician, not copied from an online chart 6.

Why some protocols split doses

Split dosing is usually discussed because short peptides may have short activity windows, and nasal delivery can vary. But the fact that a protocol is common online does not mean it has been tested in large randomized human trials 2.

Why split dosing does not mean it is safe or appropriate for an individual

Anxiety symptoms can overlap with panic disorder, depression, bipolar disorder, substance use, thyroid disease, medication effects, or sleep problems. NIMH notes that anxiety disorders can be persistent and impair daily life, which is why proper diagnosis and treatment planning matter 8.

Timing questions: morning, afternoon, and sleep concerns

Selank is often described as calming rather than sedating, but individual sleep and mood effects are not well mapped in large trials. If a substance affects anxiety, focus, or arousal, timing can matter, especially for people using psychiatric medications, sedatives, or alcohol 8.

How long does Selank take to kick in?

There is no proven Selank onset time for U.S. patients. Animal gene-expression studies can show that biological changes occur after administration, but they cannot tell you when a person will feel calmer, more focused, or different in mood 1.

What animal gene-expression studies can and cannot tell us about onset

In a rat study, Selank administration affected expression of some genes related to neurotransmission in the frontal cortex, and the researchers measured time-dependent changes after administration 1. That is useful mechanistic science, but it is not a human onset study.

Why patient reports are not the same as clinical proof

Patient reports can be sincere and still be misleading. Expectation, sleep, caffeine, alcohol, stress level, other medications, and the natural rise and fall of anxiety symptoms can all change how someone feels after taking a peptide 8.

Why effects may differ for anxiety, focus, and mood

Anxiety relief, focus, and mood are different outcomes. A compound might affect one pathway in an animal model without producing a clear or safe effect across all three outcomes in humans 1.

What does the evidence say about Selank for anxiety and cognition?

Selank has limited human evidence and more preclinical evidence than high-quality Western clinical evidence. The most honest summary is that Selank has been investigated for anxiety-like symptoms, cognition, neurotransmission, and immune signaling, but its benefits and risks are not established by large U.S.-style trials 2.

Human clinical evidence: limited, mostly Russian studies and summaries

Secondary summaries describe Russian clinical use for generalized anxiety disorder and neurasthenia, including reports that Selank was compared with benzodiazepine-type medications such as medazepam 2. These summaries also note major evidence gaps, including limited independent Western replication and limited standardized dose-response data 4.

Animal evidence: anxiety-like behavior, cognition, neurotransmission, and stress models

Animal research is helpful for understanding possible mechanisms, not for proving human outcomes. The rat gene-expression study found changes in genes related to neurotransmission after Selank administration, but it did not prove that Selank improves anxiety or cognition in people 1.

Gene-expression evidence: GABA-related and immune-related pathways

Selank is often described as affecting GABA-related pathways, including possible positive allosteric modulation of GABA-A receptor activity, along with immune-related signaling. This is different from saying it works like a benzodiazepine; benzodiazepines such as diazepam have their own FDA-reviewed labels, warnings, dependence risks, and adverse-effect profiles 9.

Evidence gaps: large Western RCTs, long-term safety, drug interactions, and standardized dosing

The key gaps are large randomized trials in diverse populations, long-term human safety, drug-interaction data, and standardized dosing by route. That matters most for people with anxiety, because delaying proven care can worsen distress and daily function 8.

What are the safety concerns with Selank dosing?

The biggest Selank safety concerns are unclear product quality, uncertain dosing, limited long-term human data, and possible interactions with psychiatric medications or other sedating substances. Any possible benefit has to be weighed against those unknowns 7.

Regulatory and quality-control risks

The FDA notes that compounded drugs are not FDA-approved and do not go through FDA review for safety, effectiveness, or quality before marketing 7. With unlicensed research-chemical sellers, the safety gap can be wider because there may be no patient evaluation, prescription, pharmacy oversight, or reliable sterility controls.

Unknown long-term safety in humans

Long-term safety data are limited in the English-language literature. For a peptide discussed for brain and mood effects, that leaves important open questions about sleep, mood switching, tolerance, withdrawal-like symptoms, and rare adverse events 4.

Potential concerns with psychiatric medications, sedatives, alcohol, or multiple peptide stacks

People taking SSRIs, benzodiazepines, sleep medicines, stimulants, mood stabilizers, alcohol, or several peptides at once should be especially cautious. Diazepam labeling includes serious warnings about sedation, respiratory depression when combined with opioids, dependence, and withdrawal, which shows why CNS-active combinations need medical review 9.

When to seek urgent medical help for anxiety or mood symptoms

Seek urgent help if anxiety comes with chest pain, fainting, suicidal thoughts, mania, psychosis, severe agitation, substance withdrawal, or thoughts of harming yourself or someone else. NIMH describes anxiety disorders as treatable medical conditions, and severe or unsafe symptoms need timely professional care 8.

What about Semax and Selank together?

Semax and Selank are often compared because both are Russian-developed neuroactive peptides. Combination protocols have less human evidence than either compound alone, so they should not be treated as established or low-risk 2.

Why people compare or stack Semax and Selank

People often frame Selank as more calming and Semax as more cognition- or stimulation-oriented, but that is a simplified online framing. Both are investigational in the United States, and neither has FDA-approved dosing for anxiety, focus, or mood 6.

Why combination protocols have even less human evidence

A combination can create effects that are not predictable from either peptide alone. Formal combination trials are limited, and online stacks do not replace controlled safety data 2.

Why changing one compound at a time matters for side-effect tracking

When more than one CNS-active compound is started at once, it becomes hard to know what caused insomnia, fatigue, mood changes, headache, anxiety changes, or other symptoms. This is one reason clinician oversight matters for peptide use, even when a compound is marketed as “gentle” or “research only” 7.

Does Chia offer Selank?

Chia does not currently offer Selank. We do offer certain clinician-reviewed longevity and wellness treatments, including NAD+, Sermorelin, and GHK-Cu Cream, but Selank is not in our live treatment catalog.

Chia does not currently offer Selank

Because Selank is not listed in our current catalog, we do not prescribe it, sell it, or route patients into a Selank protocol. This article is here to help you understand the evidence and avoid mistaking online dosing charts for medical guidance.

How Chia evaluates peptide and longevity treatments it does offer

For treatments Chia does offer, care starts with a 100% online health questionnaire. A licensed U.S. provider reviews the information and prescribes only when clinically appropriate; a prescription is never guaranteed. When prescribed, medications are compounded by state-licensed U.S. 503A pharmacies and shipped to the patient’s door.

When a licensed clinical evaluation is more appropriate than self-directed peptide use

A licensed evaluation is especially important if the goal is anxiety relief, mood support, sleep, or focus. Those symptoms can have medical, psychiatric, medication-related, or lifestyle causes, and the safest plan may not involve a peptide at all 8.

FAQ

Keep reading

Peptides

DSIP Peptide Dosage: A Patient Guide to Delta Sleep-Inducing Peptide

Peptides

Dihexa: the "million-fold BDNF" cognitive peptide — 2026 evidence-based guide

Peptides

Selank: the Russian anxiolytic nootropic peptide — 2026 evidence-based guide